← Evidence map

ReviewFrontiers in oncology2026

The methylation pattern of osimertinib resistance: prospects for diagnosis and treatment of NSCLC.

Yiting He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42840625